Literature DB >> 9072291

Cigarette smoking and coronary heart disease: risks and management.

N A Rigotti1, R C Pasternak.   

Abstract

Tobacco smoking is the leading preventable cause of death in the United States and an important cause of CHD. The effect of smoking on the cardiovascular system and coronary risk factors is pervasive. Unfavorable effects include acute increases in blood pressure and coronary vascular resistance, reduction in oxygen delivery, enhancement of platelet aggregation, increased fibrinogen, and depression of HDL cholesterol. Smoking cessation reduces cardiovascular morbidity and mortality rates relatively rapidly, even among individuals who stop smoking only after the age of 65 or after developing the clinical manifestations of CHD including myocardial infarction. Behavioral smoking-cessation programs and nicotine-replacement therapy each have been demonstrated to be effective for the treatment of smoking. The most effective treatment currently available is to combine the two. Nicotine-replacement therapy is safe and effective in patients with stable coronary heart disease. Although the threat or diagnosis of CHD is a powerful stimulus to spontaneous smoking cessation, many smokers continue to smoke after events such as myocardial infarction or CABG surgery. Studies have demonstrated that physician advice to stop smoking, supplemented by brief counseling by a nurse and follow-up, dramatically increases the smoking-cessation rate of patients hospitalized with myocardial infarction and is highly cost effective. In the outpatient setting, physician advice and counseling is also effective in helping smokers with or without CHD to stop smoking. This article outlines a simple protocol that has been demonstrated to be effective for counseling smokers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9072291     DOI: 10.1016/s0733-8651(05)70260-5

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  17 in total

1.  Vibration exposure, smoking, and vascular dysfunction.

Authors:  M Cherniack; J Clive; A Seidner
Journal:  Occup Environ Med       Date:  2000-05       Impact factor: 4.402

2.  Smoking in Saudi Arabia and its relation to coronary artery disease.

Authors:  Mansour M Al-Nozha; Yaqoub Y Al-Mazrou; Mohammed R Arafah; Mohammed A Al-Maatouq; Mohamed Z Khalil; Nazeer B Khan; Akram Al-Khadra; Khalid Al-Marzouki; Saad S Al-Harthi; Moheeb Abdullah; Maie S Al-Shahid; Abdulellah Al-Mobeireek; Mohmmed S Nouh
Journal:  J Saudi Heart Assoc       Date:  2009-08-05

3.  Risk factors and indications for readmission after lower extremity amputation in the American College of Surgeons National Surgical Quality Improvement Program.

Authors:  Thomas Curran; Jennifer Q Zhang; Ruby C Lo; Margriet Fokkema; John C McCallum; Dominique B Buck; Jeremy Darling; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2014-06-28       Impact factor: 4.268

4.  Smoking cessation is followed by increases in serum bilirubin, an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease.

Authors:  Stephanie S O'Malley; Ran Wu; Susan T Mayne; Peter I Jatlow
Journal:  Nicotine Tob Res       Date:  2014-05-08       Impact factor: 4.244

5.  Mortality and life expectancy in relation to long-term cigarette, cigar and pipe smoking: the Zutphen Study.

Authors:  Martinette T Streppel; Hendriek C Boshuizen; Marga C Ocké; Frans J Kok; Daan Kromhout
Journal:  Tob Control       Date:  2007-04       Impact factor: 7.552

6.  Trial design: blood pressure control and weight gain prevention in prehypertensive and hypertensive smokers: the treatment and prevention study.

Authors:  Mark W Vander Weg; Robert C Klesges; Jon O Ebbert; Ellen J Lichty; Margaret DeBon; Frederick North; Darrell R Schroeder; Patricia M Dubbert
Journal:  Contemp Clin Trials       Date:  2007-07-19       Impact factor: 2.226

7.  Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey.

Authors:  Arvind Bakhru; Thomas P Erlinger
Journal:  PLoS Med       Date:  2005-06-28       Impact factor: 11.069

8.  Prevalence and Pattern of Smoking among Bus Drivers of Dhaka, Bangladesh.

Authors:  Shatabdi Goon; Munmun S Bipasha
Journal:  Tob Use Insights       Date:  2014-03-09

9.  Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study.

Authors:  Tao Xu; Christina Holzapfel; Xiao Dong; Erik Bader; Zhonghao Yu; Cornelia Prehn; Katrin Perstorfer; Marta Jaremek; Werner Roemisch-Margl; Wolfgang Rathmann; Yixue Li; H Erich Wichmann; Henri Wallaschofski; Karl H Ladwig; Fabian Theis; Karsten Suhre; Jerzy Adamski; Thomas Illig; Annette Peters; Rui Wang-Sattler
Journal:  BMC Med       Date:  2013-03-04       Impact factor: 8.775

10.  Comparative Evaluation of the Impact of Subacute Exposure of Smokeless Tobacco and Tobacco Smoke on Rat Testis.

Authors:  Jonah Sydney Aprioku; Theresa Chioma Ugwu
Journal:  Int J Reprod Med       Date:  2015-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.